Kenvue Inc. $KVUE Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Key Points

• UBS Asset Management increased its Kenvue stake by 0.8% in the second quarter, adding 148,628 shares to own 17.66 million shares, or 0.92% of the company valued at approximately $337.6 million.
• Analyst sentiment remains cautious: Kenvue has an average “Hold” rating, with 12 holds and three buys, and a consensus price target of $19.27. UBS and Barclays both set a $19 target.
• Kenvue’s latest quarterly results slightly missed expectations, with $0.31 in adjusted EPS and $3.96 billion in revenue, while sales rose 3% year over year. The company paid a quarterly dividend of $0.21, equal to a 4.4% annualized yield.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 0.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,663,555 shares of the company's stock after purchasing an additional 148,628 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.92% of Kenvue worth $337,551,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in KVUE. Elyxium Wealth LLC purchased a new stake in shares of Kenvue in the fourth quarter valued at approximately $26,000. Johnson Financial Group Inc. purchased a new position in shares of Kenvue in the 2nd quarter valued at about $26,000. MV Capital Management Inc. acquired a new stake in shares of Kenvue in the fourth quarter valued at about $28,000. CoreCap Advisors LLC boosted its holdings in Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after buying an additional 591 shares in the last quarter. Finally, Reflection Asset Management acquired a new position in Kenvue during the fourth quarter worth about $32,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on KVUE. UBS Group lowered their price target on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Tuesday, August 11th. Zacks Research lowered shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. Wall Street Zen cut shares of Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Weiss Ratings upgraded shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 15th. Finally, Barclays raised their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $19.27.

Kenvue Stock Down 1.4%

Shares of NYSE:KVUE opened at $18.90 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $20.82. The stock's fifty day simple moving average is $19.18 and its 200-day simple moving average is $18.25. The company has a market capitalization of $36.30 billion, a P/E ratio of 21.72, a P/E/G ratio of 1.37 and a beta of 0.47.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion for the quarter, compared to analysts' expectations of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.29 EPS. As a group, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th were given a $0.21 dividend. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend was Wednesday, August 12th. Kenvue's dividend payout ratio (DPR) is presently 96.55%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source